Feature Channels:

Genetics

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Science

Channels:

Genetics, Fruit Flies, Cancer, Development

In Fruit Fly and Human Genetics, Timing Is Everything

McKAY_FRUITFLYWING.jpg

Every animal starts as a clump of cells, which over time multiply and mature into many different types of cells, tissues, and organs. This is fundamental biology. Yet, the details of this process remain largely mysterious. Now, scientists have begun to unravel an important part of that mystery.

Medicine

Channels:

GW School of Medicine and Health Sciences, Big Data, genetic, Gene, BRCA, Brca 1/2, Cancer, Breast Cancer, NEJM

Preliminary Study Finds BRCA Variation May Work Alongside COMT Variation to Reduce Breast Cancer Incidence

George Washington University researchers, published in the New England Journal of Medicine, find through looking at genetic data sets of presumed cancer-free women who carry BRCA 1/2 variants, the co-occurrence of a rare COMT genetic variant in some women. This research outlines a strategy for looking at large genetic data sets for clues as to why a genetic carrier may never develop the associated diseases.

Medicine

Channels:

Bicuspid Aortic Valve, Genetics, Genome, GWA

Study Implicates Two Genetic Variants in Bicuspid Aortic Valve Development

BAV.JPG

Michigan Medicine researchers report a key protein is affected during heart valve formation, in the first genomewide study of bicuspid aortic valve.

Medicine

Channels:

ISPOR Annual International Meeting, Gene Therapies, Affordability, health technology assessment, HTA

Developing and Paying for Gene Therapies: How to Measure Value?

ISPOR hosted a session this morning at its 22nd Annual International Meeting in Boston, MA, USA that examined the issue of developing and paying for gene therapies.

Medicine

Channels:

Psoriasis, Dermatology, Autoimmune Disease, immune-mediated disease, Genetics, Gene, skin

Largest Psoriasis Meta-Analysis to Date Yields New Genetic Clues

The identification of 16 additional genetic markers will help researchers get closer to understanding how — and why — psoriasis develops.

Business

Channels:

Philanthropy, Gift Announcement, duchossois group, Microbiome, Immunology, Genetics, Research, Polsky Center, Entrepreneurship, University Of Chicago, Big Data, Data Analytics

$100 Million Gift Establishes Duchossois Family Institute to Develop ‘New Science’ Focused on Optimizing Health

A Chicago-area family with a deep commitment to supporting science and medicine is giving $100 million to establish The Duchossois Family Institute at the University of Chicago Medicine, which seeks to accelerate research and interventions based on how the human immune system, microbiome and genetics interact to maintain health.

Medicine

Channels:

pembroluzimab, drug, Approval, FDA, Johns Hopkins, Drew Pardoll, Dung Le, Bert Vogelstein, Cancer, genes, Kimmel Institute, Genetics, Mismatch Repair

Media Advisory: Experts Available to Discuss Historic Cancer Drug Approval

Immunotherapy_Cancer_Tcells_iStock-486569692WEB.jpg

Today, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30 years of basic research at Johns Hopkins and its Bloomberg~Kimmel Institute, pembroluzimab now can be used for colon, pancreatic, stomach, ovarian and other cancers if genetic testing reveals defects in so-called mismatch repair genes.

Medicine

Channels:

National Institutes of Health, Grant, National Institute Of Arthritis And Musculoskeletal And Skin Diseases, Gene Therapy, Orthopedics, Bone Repair, bone injury, Bone morphogenetic protein

Keck School of Medicine of USC Receives $2.2 Million NIH Grant to Fund Research on Healing Difficult Bone Injuries

Leiberman.web.jpg

Keck School of Medicine of USC has received a $2.2 million NIH grant to fund research on gene therapy that could help manage challenging bone repairs

Medicine

Channels:

Resarch, Simmons Comprehensive Cancer Center, Cancer, Lung Cancer, Ut Southwestern

Using a Genetic Signature to Overcome Chemotherapy-Resistant Lung Cancer Using a Genetic Signature to Overcome Chemotherapy-Resistant Lung Cancer

elisabeth-martinez-body.jpg

Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences. But what if doctors could identify those at greatest risk of relapse and provide a therapy to overcome or avoid it?

Medicine

Channels:

Acute Myeloid Leukemia, Cancer, Genetics, DNA

Study Leads to Breakthrough in Better Understanding Acute Myeloid Leukaemia

A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.







Chat now!